The frequency of TP53 gene defects differs between chronic lymphocytic leukaemia subgroups harbouring distinct antigen receptors

British Journal of Haematology

Volumn 166, Issue 4, 2014, Pages 621-625

  Malcikova, Jitka ^a   Stalika, Evangelia ^b,c   Davis, Zadie ^d   Plevova, Karla ^a,e   Trbusek, Martin ^a   Mansouri, Larry ^f   Scarfò, Lydia ^g   Baliakas, Panagiotis ^c,f   Gardiner, Anne ^d   Sutton, Lesley Ann ^f   Francova, Hana Skuhrova ^e   Agathangelidis, Andreas ^g   Anagnostopoulos, Achilles ^c   Tracy, Ian ^d   Makris, Antonis ^b   Smardova, Jana ^e   Ghia, Paolo ^g   Belessi, Chrysoula ^h   Gonzalez, David ⁱ   Rosenquist, Richard ^f   Oscier, David ^d   Pospisilova, Sarka ^a   Stamatopoulos, Kostas ^b,c,f   more..

^a MASARYK UNIVERSITY   (Czech Republic)

^b INFORMATION TECHNOLOGIES INSTITUTE   (Greece)

^c G PAPANICOLAOU HOSPITAL   (Greece)

^d ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

^e UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^f UPPSALA UNIVERSITY   (Sweden)

^g VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^h GENERAL HOSPITAL OF NIKEA   (Greece)

ⁱ INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Chronic lymphocytic leukaemia; Immunoglobulin genes; Prognosis; Stereotyped B cell receptors; TP53 mutations

Indexed keywords

B LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN HEAVY CHAIN;

ADULT; CANCER PROGNOSIS; CHRONIC LYMPHATIC LEUKEMIA; COHORT ANALYSIS; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENE REARRANGEMENT; GENETIC ASSOCIATION; HUMAN; IGHD GENE; IGHJ GENE; IGHV GENE; IGHV1-69 GENE; IGHV3-21 GENE; IMMUNOGENETICS; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

CHRONIC LYMPHOCYTIC LEUKAEMIA; IMMUNOGLOBULIN GENES; PROGNOSIS; STEREOTYPED B CELL RECEPTORS; TP53 MUTATIONS;

FEMALE; GENE REARRANGEMENT, B-LYMPHOCYTE; GENES, P53; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; MUTATION; RECEPTORS, ANTIGEN;

EID: 84905021913     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12893     Document Type: Letter

References (10)

1. Agathangelidis, A., Darzentas, N., Hadzidimitriou, A., Brochet, X., Murray, F., Yan, X.J., Davis, Z., van Gastel-Mol, E.J., Tresoldi, C., Chu, C.C., Cahill, N., Giudicelli, V., Tichy, B., Pedersen, L.B., Foroni, L., Bonello, L., Janus, A., Smedby, K., Anagnostopoulos, A., Merle-Beral, H., Laoutaris, N., Juliusson, G., di Celle, P.F., Pospisilova, S., Jurlander, J., Geisler, C., Tsaftaris, A., Lefranc, M.P., Langerak, A.W., Oscier, D.G., Chiorazzi, N., Belessi, C., Davi, F., Rosenquist, R., Ghia, P. & Stamatopoulos, K. (2012) Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies. Blood, 119, 4467-4475.
2. Bomben, R., Dal Bo, M., Capello, D., Forconi, F., Maffei, R., Laurenti, L., Rossi, D., Del Principe, M.I., Zucchetto, A., Bertoni, F., Rossi, F.M., Bulian, P., Cattarossi, I., Ilariucci, F., Sozzi, E., Spina, V., Zucca, E., Degan, M., Lauria, F., Del Poeta, G., Efremov, D.G., Marasca, R., Gaidano, G. & Gattei, V. (2009) Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study. British Journal of Haematology, 144, 492-506.
3. Lin, K., Manocha, S., Harris, R.J., Matrai, Z., Sherrington, P.D. & Pettitt, A.R. (2003) High frequency of p53 dysfunction and low level of VH mutation in chronic lymphocytic leukemia patients using the VH3-21 gene segment. Blood, 102, 1145-1146.
4. Marincevic, M., Cahill, N., Gunnarsson, R., Isaksson, A., Mansouri, M., Göransson, H., Rasmussen, M., Jansson, M., Ryan, F., Karlsson, K., Adami, H.O., Davi, F., Jurlander, J., Juliusson, G., Stamatopoulos, K. & Rosenquist, R. (2010) High-density screening reveals a different spectrum of genomic aberrations in chronic lymphocytic leukemia patients with 'stereotyped' IGHV3-21 and IGHV4-34 B-cell receptors. Haematologica, 95, 1519-1525.
5. Pospisilova, S., Gonzalez, D., Malcikova, J., Trbusek, M., Rossi, D., Kater, A.P., Cymbalista, F., Eichhorst, B., Hallek, M., Döhner, H., Hillmen, P., van Oers, M., Gribben, J., Ghia, P., Montserrat, E., Stilgenbauer, S., Zenz, T. & European Research Initiative on CLL (ERIC) (2012) ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia. Leukemia, 26, 1458-1461.
6. Rossi, D., Spina, V., Bomben, R., Rasi, S., Dal-Bo, M., Bruscaggin, A., Rossi, F.M., Monti, S., Degan, M., Ciardullo, C., Serra, R., Zucchetto, A., Nomdedeu, J., Bulian, P., Grossi, A., Zaja, F., Pozzato, G., Laurenti, L., Efremov, D.G., Di-Raimondo, F., Marasca, R., Forconi, F., Del Poeta, G., Gaidano, G. & Gattei, V. (2013) Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia. Blood, 121, 4902-4905.
7. Stamatopoulos, K., Belessi, C., Moreno, C., Boudjograh, M., Guida, G., Smilevska, T., Belhoul, L., Stella, S., Stavroyianni, N., Crespo, M., Hadzidimitriou, A., Sutton, L., Bosch, F., Laoutaris, N., Anagnostopoulos, A., Montserrat, E., Fassas, A., Dighiero, G., Caligaris-Cappio, F., Merle-Béral, H., Ghia, P. & Davi, F. (2007) Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. Blood, 109, 259-270.
8. Stevenson, F.K., Krysov, S., Davies, A.J., Steele, A.J. & Packham, G. (2011) B-cell receptor signaling in chronic lymphocytic leukemia. Blood, 118, 4313-4320.
9. Strefford, J.C., Sutton, L.A., Baliakas, P., Agathangelidis, A., Malčíková, J., Plevova, K., Scarfó, L., Davis, Z., Stalika, E., Cortese, D., Cahill, N., Pedersen, L.B., di Celle, P.F., Tzenou, T., Geisler, C., Panagiotidis, P., Langerak, A.W., Chiorazzi, N., Pospisilova, S., Oscier, D., Davi, F., Belessi, C., Mansouri, L., Ghia, P., Stamatopoulos, K. & Rosenquist, R. (2013) Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2. Leukemia, 27, 2196-2199.
10. Zenz, T., Häbe, S., Denzel, T., Mohr, J., Winkler, D., Bühler, A., Sarno, A., Groner, S., Mertens, D., Busch, R., Hallek, M., Döhner, H. & Stilgenbauer, S. (2009) Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial. Blood, 114, 2589-2597.